caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1710947601

Marie Schlentz

Internal MedicineChicago, ILI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
2,289
Beneficiaries
—
Total drug cost
$120K
Distinct drugs
70
Brand share
14.5%
Top prescribed drugs
Amlodipine Besylate174 claims
Atorvastatin Calcium148 claims
Metformin Hcl93 claims
Metoprolol Succinate90 claims
Omeprazole76 claims
REFERRAL NETWORK

Where Marie Schlentz's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
LABPRO INC73286
Tony Perez
Podiatry · Chicago, IL
2376
Adam Arendt
Podiatry · Coralville, IA
1832
City Of Chicago
Ambulance Service Provider · Chicago, IL
1746
Deborah Sturgis-Hinton
Internal Medicine · Chicago, IL
1658
Laboratory Corporation Of America
Clinical Laboratory · Itasca, IL
1660
Charlie Gude
Family Practice · Oakbrook Terrace, IL
1323
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.